Tech Company Financing Transactions
Allena Pharmaceuticals Funding Round
On 3/31/2014, Allena Pharmaceuticals landed $333 thousand in funding from Frazier Healthcare Partners.
Transaction Overview
Company Name
Announced On
3/31/2014
Transaction Type
Venture Equity
Amount
$333,000
Round
Undisclosed
Investors
Frazier Healthcare Partners (James Topper)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Executive Park Dr. 202
Newton, MA 02462
USA
Newton, MA 02462
USA
Phone
Website
Email Address
Overview
Allena Pharmaceuticals (Nasdaq: ALNA) develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Louis Brenner
Chief Financial Officer
Edward Wholihan
Chief Medical Officer
Annamaria Kausz
Vice President
Geoffrey Swire
VP - Operations
Hugh Wight
VP - Regulatory Affairs
Stephen Yu
Browse more venture capital transactions:
Prev: 3/31/2014: Technorides venture capital transaction
Next: 3/31/2014: Mit Holding venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs